We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$93.3M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$64.9M
3
AMZN icon
Amazon
AMZN
+$58.3M
4
SYK icon
Stryker
SYK
+$56.3M
5
PRAH
PRA Health Sciences, Inc.
PRAH
+$49.9M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVEO
126
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$22.5M 0.23%
807,743
+394,819
+96% +$12.3M
LITE icon
127
Lumentum
LITE
$59.4B
$22.4M 0.23%
459,178
-216,618
-32% -$12.1M
QTNT
128
DELISTED
Quotient Limited Ordinary Shares
QTNT
$22.4M 0.23%
113,182
+29,353
+35% +$5.64M
PRA
129
DELISTED
ProAssurance
PRA
$22.1M 0.23%
387,500
+17,500
+5% +$1.02M
AXON
130
Axon Enterprise
AXON
$40.5B
$20.6M 0.21%
778,326
-192,237
-20% -$4.62M
AFL icon
131
Aflac
AFL
$63.9B
$20.6M 0.21%
468,500
+9,000
+2% +$384K
AKAO
132
DELISTED
Achaogen Inc
AKAO
$20.2M 0.21%
1,881,380
-21,078
-1% -$265K
TWOU
133
DELISTED
2U Inc
TWOU
$19.9M 0.21%
+10,280
New +$19.3M
UBS icon
134
UBS Group
UBS
$170B
$19.4M 0.2%
1,032,414
+113,917
+12% +$1.98M
WWE
135
DELISTED
World Wrestling Entertainment
WWE
$19.2M 0.2%
633,687
+578,107
+1,040% +$15.6M
CYBR
136
DELISTED
CyberArk
CYBR
$19.1M 0.2%
462,144
-51,250
-10% -$2.24M
RLI icon
137
RLI Corp
RLI
$5.68B
$18.6M 0.19%
613,800
+12,000
+2% +$352K
ALGN icon
138
Align Technology
ALGN
$12B
$17.2M 0.18%
+76,227
New +$17.3M
MRK icon
139
Merck
MRK
$324B
$17.1M 0.18%
318,871
– –
DHR icon
140
Danaher
DHR
$135B
$16.9M 0.17%
205,928
– –
MDGL icon
141
Madrigal Pharmaceuticals
MDGL
$12.6B
$16.5M 0.17%
+180,000
New +$10.3M
BDX icon
142
Becton Dickinson
BDX
$43.1B
$16.5M 0.17%
78,925
-15,064
-16% -$3.15M
WOLF icon
143
Wolfspeed
WOLF
$1.2B
$16.1M 0.17%
434,200
+86,791
+25% +$2.99M
PNC icon
144
PNC Financial Services
PNC
$100B
$15.7M 0.16%
108,667
+13,300
+14% +$1.84M
TD icon
145
Toronto Dominion Bank
TD
$198B
$15.4M 0.16%
234,510
+16,255
+7% +$929K
EXEL icon
146
Exelixis
EXEL
$13.9B
$15.2M 0.16%
500,000
+400,000
+400% +$10.6M
AXS icon
147
AXIS Capital
AXS
$8.59B
$15.1M 0.16%
300,000
– –
REGN icon
148
Regeneron Pharmaceuticals
REGN
$68.8B
$15M 0.16%
40,000
+22,500
+129% +$9.11M
DATA
149
DELISTED
Tableau Software, Inc.
DATA
$14.7M 0.15%
+212,100
New +$15.6M
VAR
150
DELISTED
Varian Medical Systems, Inc.
VAR
$14.3M 0.15%
+128,245
New +$13.8M
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.